{"pub": "investing.com", "url": "https://au.investing.com/news/stock-market-news/jj-earnings-revenue-beat-in-q3-1972455", "downloaded_at": "2019-10-15 11:26:34.827243+00:00", "title": "J&J Earnings, Revenue beat in Q3", "language": "en", "text": "\u00a9 Reuters. J&J Earnings, Revenue beat in Q3\n\nInvesting.com - J&J (NYSE: ) reported third quarter that beat analysts' expectations on Tuesday and revenue that topped forecasts.\n\nThe firm reported earnings per share of $2.12 on revenue of $20.73B. Analysts polled by Investing.com expected EPS of $2 on revenue of $20.1B. That compared to EPS of $2.05 on revenue of $20.35B in the same period a year earlier. The company had reported EPS of $2.58 on revenue of $20.56B in the previous quarter.\n\nFor the year, J&J shares are up 1.29%, under-performing the which is up 16.17% year to date.\n\nJ&J follows other major Healthcare sector earnings this month\n\nOn Tuesday, October 8, 2019, Helen of Troy Ltd reported second quarter EPS of $2.24 on revenue of $414M, compared to forecasts of EPS of $1.88 on revenue of $391.86M.\n\nNeogen earnings missed analyst's expectations on Tuesday, September 24, 2019, with first quarter EPS of $0.28 on revenue of $101.42M. Investing.com analysts expected EPS of $0.3 on revenue of $105.16M\n\nStay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar", "description": "J&J Earnings, Revenue beat in Q3", "authors": [], "top_image": "https://i-invdn-com.akamaized.net/news/LYNXNPEB5S0BT_L.jpg", "published_at": "2019-10-15"}